Skip to main navigation Skip to search Skip to main content

New highly specific agonistic peptides for human melanocortin MC1 receptor

  • Michael Szardenings
  • , Ruta Muceniece
  • , Ilze Mutule
  • , Felikss Mutulis
  • , Jarl E.S. Wikberg*
  • *Corresponding author for this work
  • Uppsala University
  • Melacure Therapeutics AB

Research output: Contribution to journalArticlepeer-review

45 Citations (Scopus)

Abstract

A peptide with very high specificity for the human melanocortin MC1 receptor identified by phage display was used as a lead for the design of new peptides. Two new peptides, MS05 and MS09, were synthesized and found to bind with sub-nanomolar affinities to the MC1 receptor. Both these peptides showed strong agonistic activity at the MC1 receptor. The MS05 was the most MC1 receptor selective as it showed virtually no binding affinity for the MC4 and MC5 receptors and only micromolar affinity for the MC3 receptor. The selectivity and potency of the new peptides make them potent tools for studies of MC1 receptors, as well as novel potential candidate drugs for the treatment of inflammatory conditions. Copyright (C) 2000 Elsevier Science Inc.

Original languageEnglish
Pages (from-to)239-243
Number of pages5
JournalPeptides
Volume21
Issue number2
DOIs
Publication statusPublished - Feb 2000
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Melanocortin receptors
  • Melanocyte stimulating hormone
  • Receptor selective peptides

Fingerprint

Dive into the research topics of 'New highly specific agonistic peptides for human melanocortin MC1 receptor'. Together they form a unique fingerprint.

Cite this